Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04999826 · ClinicalTrials.gov registry record
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 105
- Enrollment target
NCT04999826: Completed study, sponsored by Mayo Clinic.
NCT04999826 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04999826 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
This study gathers information to create a database to improve the ability to diagnose cancer, predict long term health of breast cancer patients, and help develop future treatment products. This study will provide a foundational platform for therapeutic development and intervention studies in the future and may for therapeutic development and intervention studies in the future, and may advance researchers understanding of the contribution gut bacteria to altered circulating estrogens in breast cancer survivors.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04999826
The ClinicalTrials.gov registry entry for NCT04999826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04999826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04999826 about?
NCT04999826 is a clinical study titled "Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors". This study gathers information to create a database to improve the ability to diagnose cancer, predict long term health of breast cancer patients, and help develop future treatment products. This study will provide a foundational platform for therapeutic development and intervention studies in the f...
What is the current status of trial NCT04999826?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2021-04-01. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04999826?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04999826?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.